[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Mach et al., 2008 - Google Patents

Reducing microbial contamination risk in biotherapeutic manufacturing

Mach et al., 2008

View PDF
Document ID
5757580606928079588
Author
Mach C
Riedman D
Publication year
Publication venue
BioProcess International

External Links

Snippet

The risk of contamination (especially microbiological) is always an area for special attention in biopharmaceutical processes. No matter the process stage, whether upstream of a bioreactor or in the final filling of a sterile product, effective contamination control continues …
Continue reading at eu-assets.contentstack.com (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/04Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/20Material Coatings

Similar Documents

Publication Publication Date Title
TW308644B (en)
EP1135459A1 (en) Method for culturing microorganisms in prefilled flexible containers
Allison et al. Current status and future trends for disposable technology in the biopharmaceutical industry
Sigward et al. Aseptic simulation test challenged with microorganisms for validation of pharmacy operators
Sandle et al. Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals
Mach et al. Reducing microbial contamination risk in biotherapeutic manufacturing
EP2840379B1 (en) An automated test method for testing risk and integrity of pharmaceutical filtration membranes
US20190359930A1 (en) Method for sampling fluid streams for monitoring contaminants in a continuous flow
Watson et al. Scalable isolation and purification of extracellular vesicles from Escherichia coli and other bacteria
GERMS Group False‐positive alarms for bacterial screening of platelet concentrates with BacT/ALERT new‐generation plastic bottles: a multicenter pilot study
Galliher Single use technology and equipment
Plavsic An integrated approach to ensure the viral safety of biotherapeutics
EP3141594A2 (en) Method for sampling fluid streams for monitoring contaminants in a continuous flow
Hampson Closed processing for cell therapies: engineering risk reduction and patient safety during manufacturing
Roesti Microbiological examination of non‐sterile final dosage forms and raw material including acceptance criteria and testing frequency
Jornitz et al. Single-use Equipment–The
Pendlebury Cell & Gene Therapies: A Guide To Single-Use Connections-10 Transferable Lessons From The Bioprocessing Industry
Ebinuma et al. Sterilization in pharmaceutical biotechnology
Amipara Manufacturing of dry powder injection of cefoperazone+ sulbactam 1.5 gm IP
Ebinuma et al. 8 Sterilization in Pharmaceutical Biotechnology
Pendlebury CELL & GENE THERAPIES: A GUIDE TO SINGLE-USE CONNECTIONS
GRUENER Guide to Irradiation and Sterilization Validation of Single-Use Bioprocess Systems
Cooper et al. Bacterial endotoxin test and sterility test for radiopharmaceuticals
Wassard et al. Rapid Implementation of a Smallpox Vaccine Facility
Weissfeld et al. Microbial monitoring in the pharmacy